Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 2/3 2Phase 4 1Phase 3 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 3Lymphoid 1

Conditions

Thrombocytopenia 3Leukemia, Myeloid, Acute 2Pathologic Complete Response 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Jacobs syndrome 1

Interventions

eltrombopag 3romiplostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Busulfan 2Vitamin E 1Tranexamic Acid 1Topotecan 1Thrombopoietin 1Saline Solution 1Radiotherapy 1Moxibustion 1Microarray Analysis 1Isotretinoin 1Ifosfamide 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Doxorubicin 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cord Blood Stem Cell Transplantation 1Carboplatin 1CP protocol 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Thrombocytopenia × eltrombopag × Clear all
NCT02323178 2021-04-20

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Groupe Francophone des Myelodysplasies

Phase 1/2 Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

NCT01656252 2020-11-03

PrE0901

PrECOG, LLC.

Phase 1/2 Terminated
15 enrolled 5 charts
Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01397149 2015-05-28

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

University of Ulm

Phase 1/2 Terminated
4 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡